Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC]

Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] was reported 0 times

Drugs of the Bispecific B Cell Maturation Antigen-directed CD3 T Cell Engager [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency